Three companies have merged to form the UK’s first nationwide life sciences ecosystem, boosting R&D and drug discovery capacity in the country and giving early-stage companies access to much-needed investment and facilities.
BioCity with its 29 earlier investments in life science ventures, specialises in seed funding via convertible loans for very early-stage ventures and co-investment in growing life science ventures.